MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Atopiclair - innovative non-steroidal cream for atopic dermatitis

Sinclair Pharmaceuticals
New cream formulation to manage the symptoms of atopic dermatitis.

Mechanism of action

Multi-functional

Full description

Atopiclair is a new non-steroidal cream, which has been especially formulated to manage the symptoms of atopic dermatitis. It acts by adhering to the injured tissue and protecting it from further irritation and also maintains a moist wound and skin environment, which is beneficial to the healing process. Efficacy in relieving the symptoms of atopic dermatitis, has been demostrated in controlled studies.

 

 

Development status

Registered

Patent information

Patents pending.

Type of business relationship sought

Exclusive agreements on a territory and/or regional basis for the marketing and distribution of a finished product.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Need competitive intelligence information
Profile your company today
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us